期刊文献+

CRP与心肌肌钙蛋白I在心力衰竭诊断中的意义 被引量:1

The significance of CRP and cardiac troponin I in the diagnosis of heart failure
下载PDF
导出
摘要 目的探讨CRP与心肌肌钙蛋白I(cTnI)在慢性心力衰竭临床诊断中的意义。方法选取2011年9月~2013年11月在本院进行诊治的慢性心力衰竭患者80例作为观察组,同期选取在本院进行体检的健康人80例作为对照组,两组都进行CRP与cTnI的检测与判断。结果观察组的CRP、cTnI水平明显高于对照组,差异有统计学意义(P〈0.05)。观察组的CRP、cTnI阳性率分别为70.0%、77.5%,明显高于对照组的3.8%、5.0%,差异有统计学意义(P〈0.05)。结论CRP与cTnI在临床上对慢性心力衰竭的诊断有很好的价值,值得推广应用。 Objective To investigate clinical significance of CRP and cardiac troponin I(cTnI)in the diagnosis of chron- ic heart failure. Methods 80 cases of patients with chronic heart failure from September 2011 to November 2013 in our hospital were selected as observation group,the same period in our hospital for medical examination of 80 cases of healthy people were selected as control group,the serum CRP and cTnI in two groups was detected respectively. Results The level of CRP and cTnI in observation group was significantly higher than that in control group respectively,with statistical difference (P〈0.05).The positive rate of CRP and cTnI in observation group was 70.0% and 77.5% respectively,significantly higher than that in control group(3.8%,5.0%),with statistical difference(P〈0.05). Conclusion CRP and cTnI in the diagnosis of chronic heart failure in clinic has better value,which is worthy of promotion and application.
作者 梁春玲
出处 《中国当代医药》 2014年第16期50-51,共2页 China Modern Medicine
关键词 C-反应蛋白 心肌肌钙蛋白I 慢性心力衰竭 诊断 C-reactive protein Cardiac troponin I Chronic heart failure Diagnosis
  • 相关文献

参考文献11

二级参考文献45

  • 1孙子迪.基于环境艺术设计中的生态理念研究[J].中外企业家,2020,0(4):232-232. 被引量:6
  • 2贺桦,许顶立,刘彦波,屠燕.慢性心力衰竭患者血清CRP水平的变化及临床意义[J].中国分子心脏病学杂志,2004,4(2):114-117. 被引量:13
  • 3乔延国,井茹芳,李卉,黄志刚,梁立武,韩盈.心衰康复治疗中脑利钠肽的恢复与心功能改善的关系[J].实用医学杂志,2006,22(11):1253-1254. 被引量:5
  • 4[2]Ridker PM,Glynn RJ,Hennekens CH.C-reactive protein adds to the predictive value of total and HDL cholesterol in determining risk of first myocardial infarction.Circulation,1998,97:2007~2011.
  • 5[3]Ferranti SD,Rifai N.C-reactive protein and cardiovascular disease:a review of risk prediction and intervention.Clin Chim Acta.2002,317;1~15.
  • 6[4]Hunt SA,Baker DW,Chim MH,et al.ACC/AHA Guidelines for the Evaluation and Management of Chronic heart failure in the Adult..Executive Summary A Report of the American College Of Cardiology/ American Heart Association Task Force on Practice Guidelines (committee to revise the 1995 Guidelines for the Evaluations and Management of Heart Failure).Circulation,2001,104(24):2996~3007.
  • 7[5]Maisel A.B-Type Natriuretic Peptide Levels:Diagnostic and Prognostic in Congestive Heart Failure:What's Next? Circulation,2002 105:2328~2331.
  • 8[6]Berger R,Huelsmann M,Samson S,et al.B-type natriuretic peptide predicts sudden death in patients with chronic heart failure-A selection mode for ICD implantation.J Am Coll Cardiol,2002,39(suppl B):193B.
  • 9[8]Arici M,Walls J.End-stage renal disease,antheroscerlosis and cardiovascular mortality:Is C-reaactive protein in the miss link?.Kidney Int,2001,59:407.
  • 10[9]Werdan K.The activated immune system in congestive heart failure.From dropsy to the cytokine paradigm.J Intern Med 1998,243:87~92.

共引文献130

同被引文献7

引证文献1

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部